Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information on how we use and manage cookies please take a look at our privacy and cookie policies. Some parts of the site may not work properly if you choose not to accept cookies.

sections
Home > Zebra Technologies > White Paper: Benefiting from Bedside Specimen Labeling
 

White Paper: Benefiting from Bedside Specimen Labeling

White Paper Published By: Zebra Technologies
Zebra Technologies
Published:  Jun 15, 2017
Type:  White Paper
Length:  8 pages

Labeling blood and other samples at the time they are collected improves patient safety and helps prevent a host of problems related to misidentification ó including many of the estimated 160,900 adverse events that occur in U.S. hospitals annually because of sample identification errors. There is a strong and growing body of evidence within medical literature that creating specimen identification labels on demand at the patient bedside with a mobile printer can significantly reduce errors. The Joint Commissionís National Patient Safety Goals (NPSG) advocate the use of two patient-specific identifiers, such as name and birthdate, whenever taking blood or other samples from a patient, and to label the sample collection container in the presence of the patient.



Tags : 
specimen, labeling, benefit, hospitals